GSK withdraws Zantac drugs from local market: Health Bureau
London-based multinational pharmaceutical company GSK has informed a local importer of medicines that it has decided to withdraw four of its drugs sold under the brand name Zantac from the local market, the Health Bureau (SSM) said in a statement on Tuesday.According to the statement, the four drugs to be withdrawn from the market are Zantak Tablet 150mg, Zantac Tablet 300mg, Zantac Syrup 150mg/10ml, and Zantac Injection 25mg/ml. According to recent international newswire reports, Zantac, which
September 26, 2019 | BY admin